期刊文献+

^(99)Tc^m-H-Annexin V动物体内分布及显像 被引量:6

Study on biodistribution and imaging of ^(99)Tc^m-H-Annexin V in normal animals
下载PDF
导出
摘要 目的:探讨99Tcm标记重组改良型人膜联蛋白V(H-Annexin V)在健康小鼠体内的生物分布及在健康家兔体内的动态显像表现。方法:以99Tcm直接标记H-Annexin V,然后测定标记率,并计算其比活度。研究99Tcm-H-Annexin V于1,10,30,60,120和240min在健康小鼠体内的生物分布特性;通过SPECT显像,运用感兴趣区(ROI)时间-放射性曲线分析,观察在240min内99Tcm-H-Annexin V在健康家兔体内的动态分布变化。结果:99Tcm-H-Annexin V标记率为(96.80±0.35)%,比活度为(12.30±0.06)TBq/mmol。小鼠血液放射性清除迅速,肾脏排泄较快,其余组织器官放射性均随时间逐渐降低,而脑放射性水平始终最低;家兔各器官放射性均随时间逐渐下降,与同一时间肾、心、肝相比,肺、胃、肌肉放射性呈低水平。结论:99Tcm-H-Annexin V制备方法简便,标记率高,体内稳定性好,具有比较理想并符合实际的动物体内动力学表现。 Objective: To investigate the biodistribution of ^99Tc^m-H-Annexin V in normal mice and rabbit. Methods: H-Annexin V was labeled directly with 9Wcm. The labeling rate was determined and the specific activity was calculated. The biodistrbution of ^99Tc^m-H-Annexin V was studied at 1, 10, 30, 60, 120 and 240min after injection in normal mice. The scintigraphy of ^99Tc^m-H-Annexin V was performed in normal rabbit for 240min, combining the region of interest(ROI) time-activity curve analysis. Results: The radiolabeling rate and specific activity of ^99Tc^m-H-Annexin V were (96.80±0.35)% and (12.30±0.06)TBq/mmol respectively. Biodistribution in mice showed rapid blood and renal clearance with gradually excreted in other organs or tissues including heart, liver, lungs, and muscle. Low uptake at brain was also observed throughout the whole course of the studies. In rabbit, rapid uptake and clearance in the genito-urinary system with gradually decreased uptake with time in other organs or tissues was observed. Conclusion: ^99Tc^m-H-Annexin V is an easily prepared and labeled compound with high labeling efficiency and stability.
出处 《中国临床医学影像杂志》 CAS 北大核心 2008年第1期56-58,共3页 Journal of China Clinic Medical Imaging
关键词 膜联蛋白A5 同位素标记 动物实验 药代动力学 Annexin A5 Isotope labeling Technetium Animal experimentation Phannacokinetics
  • 相关文献

参考文献8

  • 1Tait JF. Clinical application of Annexins. Molecular structure to cellular function[M]. New York: RG Landes, 1996. 213-220. 被引量:1
  • 2Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual[M]. New York: Cold Spring Harbor Laboratory, 1989. 被引量:1
  • 3George AJT, Jamar F, Meisheng T, et al. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: ^99Tc^m coordination by singlechain Fv antibody fusion proteins through a terminal cysteinyl peptide [J]. PNAS, 1995, 92 (18): 8358-8362. 被引量:1
  • 4Bogdanoc A, Simonova J, Weissleder R. Design of metal binding green fluorescent protein variants[J]. Biochem Biophys Acta, 1998, 1397: 56-64. 被引量:1
  • 5鞠成伟,王连生,杨翔,马根山,华子春,高兴亚.人胎盘抗凝蛋白变体的抗凝与抗栓作用[J].中华血液学杂志,2004,25(9):540-543. 被引量:8
  • 6朱霖,刘锰,沈锐,何作祥.Annexin Ⅴ在核医学细胞凋亡显像中的应用[J].中华核医学杂志,2004,24(6):379-381. 被引量:10
  • 7Tait JF, Brown DS, Gibson DF, et al. Development and characterization of Annexin V mutants with endogenous chelation site for ^99Tc^m[J]. Bioconjugate Chem, 2000, 11(6): 918-925. 被引量:1
  • 8Blankenberg FG, Tait JF, Strauss HW. Apoptosis cell death: its implications for imaging in the next millennium [J]. Eur J Nucl Med, 2000, 27(2): 359-367. 被引量:1

二级参考文献37

  • 1Neuhaus KL,von Essen R, Tebbe U, et al. Safety observations from the pilot phase of the randomized r-Hirudin for improvement of Thrombolysis ( HIT-Ⅲ ) study. Circulation, 1994, 90:1638-1642. 被引量:2
  • 2Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence of phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem, 1991, 266:24302-24307. 被引量:1
  • 3Tait JF, Cerqueira MD, Dewhurst TA, et al. Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res, 1994, 75:491-501. 被引量:2
  • 4Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) Ⅱ a Investigators. Circulation, 1994, 90:1631-1637. 被引量:2
  • 5Blankenberg FG, Strauss HW. Non-invasive diagnosis of acute heart- or lung-trnsplant rejection using radiolabeled annexin V. Pediatr Radiol,1999,29: 299-305. 被引量:1
  • 6吴梧桐,主编.现代生化药学.北京:中国医药科技出版社,2002.273-301. 被引量:1
  • 7Van Heerde WL, Robert-Offerman S, Dumont E, et al. Markers of apoptosis in cardiovascular tissue: focus on Annexin V. Cardiovasc Res,2000, 45: 549-559. 被引量:1
  • 8Blankenberg FG, Katsikis PD,Tait JF,et al. In vivo detection and imaging of phosphatidylserrine expression during programmed cell death. Proc Natl AcadSci USA, 1998, 95:6349-6354. 被引量:1
  • 9Blankenberg F, Ohtsuki K, Strauss H-W. Dying a thousand deaths. Radionuclide imaging of apoptosis. Q J Nucl Med, 1999, 43: 170-176. 被引量:1
  • 10Blankenberg F, Tait JF, Strauss HW. Apoptosis cell death: its implications for imaging in the next millennium. Eur J Nucl Med, 2000, 27:359-367. 被引量:1

共引文献16

同被引文献37

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部